These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35335964)

  • 1. Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs.
    Pires PC; Rodrigues M; Alves G; Santos AO
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies.
    Pires PC; Santos AO
    J Control Release; 2018 Jan; 270():89-100. PubMed ID: 29199063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of an ex vivo fosphenytoin nasal bioconversion/permeability evaluation method.
    Antunes Viegas D; Rodrigues M; Francisco J; Falcão A; Alves G; Santos AO
    Eur J Pharm Sci; 2016 Jun; 89():61-72. PubMed ID: 27106504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Emulsifying Drug Delivery Systems: An Alternative Approach to Improve Brain Bioavailability of Poorly Water-Soluble Drugs through Intranasal Administration.
    Meirinho S; Rodrigues M; Santos AO; Falcão A; Alves G
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotics-Loaded Nanometric Emulsions for Brain Delivery.
    Pires PC; Paiva-Santos AC; Veiga F
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nose-to-brain delivery of phenytoin and its hydrophilic prodrug fosphenytoin combined in a microemulsion - formulation development and in vivo pharmacokinetics.
    Pires PC; Fazendeiro AC; Rodrigues M; Alves G; Santos AO
    Eur J Pharm Sci; 2021 Sep; 164():105918. PubMed ID: 34174414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chirally Pure Prodrugs and Their Converting Enzymes Lead to High Supersaturation and Rapid Transcellular Permeation of Benzodiazepines.
    Kapoor M; Cheryala N; Rautiola D; Georg GI; Cloyd JC; Siegel RA
    J Pharm Sci; 2016 Aug; 105(8):2365-71. PubMed ID: 27342435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal fosphenytoin: The promise of phosphate esters in nose-to-brain delivery of poorly soluble drugs.
    Pires PC; Santos LT; Rodrigues M; Alves G; Santos AO
    Int J Pharm; 2021 Jan; 592():120040. PubMed ID: 33157214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
    Hu X; Yue X; Wu C; Zhang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):328-337. PubMed ID: 37476944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-soluble benzodiazepine prodrug/enzyme combinations for intranasal rescue therapies.
    Siegel RA; Kapoor M; Cheryala N; Georg GI; Cloyd JC
    Epilepsy Behav; 2015 Aug; 49():347-50. PubMed ID: 26115606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of a soluble diazepam prodrug to supersaturated diazepam for rapid intranasal delivery: Kinetics and stability.
    Rautiola D; Cloyd JC; Siegel RA
    J Control Release; 2018 Nov; 289():1-9. PubMed ID: 30227158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
    Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
    J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Coadministration of a Diazepam Prodrug with a Converting Enzyme Results in Rapid Absorption of Diazepam in Rats.
    Rautiola D; Maglalang PD; Cheryala N; Nelson KM; Georg GI; Fine JM; Svitak AL; Faltesek KA; Hanson LR; Mishra U; Coles LD; Cloyd JC; Siegel RA
    J Pharmacol Exp Ther; 2019 Sep; 370(3):796-805. PubMed ID: 30837282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid delivery of diazepam from supersaturated solutions prepared using prodrug/enzyme mixtures: toward intranasal treatment of seizure emergencies.
    Kapoor M; Winter T; Lis L; Georg GI; Siegel RA
    AAPS J; 2014 May; 16(3):577-85. PubMed ID: 24700272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrug/Enzyme based acceleration of absorption of hydrophobic drugs: an in vitro study.
    Kapoor M; Siegel RA
    Mol Pharm; 2013 Sep; 10(9):3519-24. PubMed ID: 23937162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs.
    Kao HD; Traboulsi A; Itoh S; Dittert L; Hussain A
    Pharm Res; 2000 Aug; 17(8):978-84. PubMed ID: 11028945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of drug delivery to the brain via nasal route.
    Kozlovskaya L; Abou-Kaoud M; Stepensky D
    J Control Release; 2014 Sep; 189():133-40. PubMed ID: 24997277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration:
    Silva S; Bicker J; Fonseca C; Ferreira NR; Vitorino C; Alves G; Falcão A; Fortuna A
    Front Pharmacol; 2021; 12():751321. PubMed ID: 34925013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: In-vitro/in-vivo evaluation.
    Fouad SA; Shamma RN; Basalious EB; El-Nabarawi MA; Tayel SA
    Int J Pharm; 2016 May; 505(1-2):212-22. PubMed ID: 27063851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.